The Pharmaceutical Industry Key events and
trends shaping its current status and future direction
Analysis of future trends expected to impact the market in 2006 and beyond...
Despite a tough year in 2005 in terms of the regulatory environment and public
opinion, a number of leading pharmaceutical companies continued to drive
impressive growth.
This new report reviews the current position of the prescription
pharmaceutical industry through the performance of the leading companies and
evaluates the key trends shaping its future.
Understand the developments of leading pharmaceutical companies including
share price performance, merger and alliance activity, and overall growth by
ordering you report today!
Some key findings from this new report...
-
Genentech was the fastest growing of the top 50 pharma and biotech companies
in 2005
with an impressive 46.4% sales growth rate building on sales of $3,749m in
2004. Datamonitor also forecasts it will have the fastest growth in 2006
-
2006 looks set to see the launch of products with massive potential:
Sanofi-Aventis' Acomplia for the treatment of obesity and smoking cessation
and Pfizer's inhalable insulin Exubera both have considerable sales
potential
The report provides...
-
Key products driving industry growth:
-
Top selling products including Lipitor and Plavix
- Largest percentage sales growth including Tarceva
and Lyrica
- Major new launches and much more...
-
Prescription sales growth forecasts
-
2005 licensing revenue and forecasts for 2006:
In 2005 Revenue generated by top companies from in-licensed products
surpassed $100 billion for the first time, the trend looks to continue in
2006
Identify the critical factors that have both driven and hindered growth in the
pharmaceutical industry with this new report's:
-
Identification of the products driving market growth
and the patent expiries that are expected to slow growth over the coming
year
-
Winners and losers of 2005:
An in-depth examination revealing the winners and losers in terms of sales
growth and share price performance
-
2006 pharmaceutical sales forecasts
and a focus on products with considerable sales potential including Acomplia
and Exubera.
Report information:
>
Price:
$7,600
>
Published:
March- 06
> Format:
PDF
To purchase click the title:
The Pharmaceutical Industry Key events and trends shaping its current status
and future direction
